Pharmacokinetics and Bioequivalance of Clarithromycin Dispersed Tablet in Healthy Volunteers

CHENG Xiao-hua,ZHANG Hong,ZHANG Xin-jing,XIONG Yu-qing
DOI: https://doi.org/10.3969/j.issn.1000-2294.2006.01.012
2006-01-01
Abstract:Objective To investigate pharmacokinetic of clarithromycin dispersed tablet and to evaluate the bioequivalance of the two dispersed tablets.Methods Eighteen volunteers were randomly divided into 2 groups.A single oral dose of 500 mg of test or reference dispersed tablet were given to each volunteer in an open crossover test.The plasma concentration of clarithromycin was determined by HPLC-UV.The parameters of pharmacokintic and relative bioavailability were calculated,the bioequivalance of two dispersed tablets were calculated too.Results The main pharmacokinetic parameters of test and reference Clarithromycin were as the followings:AUC_(0~24) was(20.51±5.90)μg/(mL·h) and(19.58±5.73)μg/(mL·h);Cmax was(3.34±(1.24))μg/(mL·h) and(3.31±1.27)μg/(mL·h);Tmax was(1.6±0.5)h and(1.4 ±0.3)h;t_(1/2) was(7.06±1.45)h and(6.93±1.20) h.The relative bioavailability of test to reference preparation was(112.3 ± 43.3)%.Conclusion The two preparations are bioequivalent.
What problem does this paper attempt to address?